Page last updated: 2024-08-23

pravastatin and Hyperchylomicronemia Late Onset

pravastatin has been researched along with Hyperchylomicronemia Late Onset in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (20.00)	18.7374
1990's	1 (20.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Díaz Rodríguez, Á	1
Romaniv, S; Vecka, M; Zák, A; Zeman, M	1
Barrett, PH; Dunn, J; Parhofer, KG; Schonfeld, G	1
Athyros, VG; Kontopoulos, AG; Papageorgiou, AA	1
Saito, Y; Yoshida, S	1

Trials

3 trial(s) available for pravastatin and Hyperchylomicronemia Late Onset

Article	Year
[Long-term hypolipidemic treatment of mixed hyperlipidemia with a combination of statins and fibrates]. Casopis lekaru ceskych, 2003, Volume: 142, Issue:8 Topics: Adult; Aged; Anticholesteremic Agents; Clofibric Acid; Drug Therapy, Combination; Female; Fenofibrate; Fibric Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type V; Hypolipidemic Agents; Male; Middle Aged; Pravastatin; Simvastatin	2003
Effect of pravastatin on metabolic parameters of apolipoprotein B in patients with mixed hyperlipoproteinemia. The Clinical investigator, 1993, Volume: 71, Issue:11 Topics: Adult; Apolipoproteins B; Double-Blind Method; Humans; Hyperlipoproteinemia Type V; Kinetics; Lipids; Male; Middle Aged; Pravastatin	1993
Statin-fibrate combinations in patients with combined hyperlipedemia. Atherosclerosis, 2001, Volume: 155, Issue:1 Topics: Clofibric Acid; Coronary Disease; Drug Therapy, Combination; Fibric Acids; Follow-Up Studies; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemia, Familial Combined; Hyperlipoproteinemia Type V; Hypolipidemic Agents; Myocardial Infarction; Pravastatin; Simvastatin; Stroke	2001

Other Studies

2 other study(ies) available for pravastatin and Hyperchylomicronemia Late Onset

Article	Year
[The fixed combination of pravastatin and fenofibrate: what can it provide?]. Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis, 2014, Volume: 26 Suppl 1 Topics: Atherosclerosis; Cardiovascular Diseases; Drug Combinations; Dyslipidemias; Fenofibrate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type V; Hypolipidemic Agents; Pravastatin; Risk Factors	2014
[Recent trend in the research of hyperlipidemia in Japan. Treatment of refractory hyperlipidemia]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1989, Volume: 78, Issue:10 Topics: Anticholesteremic Agents; Bezafibrate; Blood Component Removal; Cholesterol; Drug Therapy, Combination; Heptanoic Acids; Humans; Hyperlipoproteinemia Type I; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type V; Hyperlipoproteinemias; Naphthalenes; Pravastatin; Probucol; Triglycerides	1989

Article

Year

[The fixed combination of pravastatin and fenofibrate: what can it provide?].

Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis, 2014, Volume: 26 Suppl 1

Topics: Atherosclerosis; Cardiovascular Diseases; Drug Combinations; Dyslipidemias; Fenofibrate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type V; Hypolipidemic Agents; Pravastatin; Risk Factors

2014

[Recent trend in the research of hyperlipidemia in Japan. Treatment of refractory hyperlipidemia].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1989, Volume: 78, Issue:10

Topics: Anticholesteremic Agents; Bezafibrate; Blood Component Removal; Cholesterol; Drug Therapy, Combination; Heptanoic Acids; Humans; Hyperlipoproteinemia Type I; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type V; Hyperlipoproteinemias; Naphthalenes; Pravastatin; Probucol; Triglycerides

1989